314 related articles for article (PubMed ID: 20216421)
1. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
Lienhardt C; Vernon A; Raviglione MC
Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
Ma Z; Lienhardt C
Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
5. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities in developing novel drugs for TB.
Kaneko T; Cooper C; Mdluli K
Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843
[TBL] [Abstract][Full Text] [Related]
7. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
Lienhardt C; Davies G
Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
[TBL] [Abstract][Full Text] [Related]
8. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis drug development: progress, challenges, and the road ahead.
Ginsberg AM
Tuberculosis (Edinb); 2010 May; 90(3):162-7. PubMed ID: 20382086
[TBL] [Abstract][Full Text] [Related]
10. Management of multidrug-resistant tuberculosis: an update.
Monedero I; Caminero JA
Ther Adv Respir Dis; 2010 Apr; 4(2):117-27. PubMed ID: 20388724
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
12. Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective.
Sacks LV; Behrman RE
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S93-100. PubMed ID: 18762157
[TBL] [Abstract][Full Text] [Related]
13. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century.
Burman WJ
Clin Infect Dis; 2010 May; 50 Suppl 3():S165-72. PubMed ID: 20397944
[TBL] [Abstract][Full Text] [Related]
14. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
18. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives.
Migliori GB; Centis R; Lange C; Richardson MD; Sotgiu G
Curr Opin Pulm Med; 2010 May; 16(3):171-9. PubMed ID: 20134324
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for the treatment of tuberculosis.
Yew WW; Cynamon M; Zhang Y
Expert Opin Emerg Drugs; 2011 Mar; 16(1):1-21. PubMed ID: 20868293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]